Morbid obese patient frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss five years after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.
To evaluate effect on comorbid disease and weight loss five years after Roux-en-Y gastric bypass (RYGB) surgery for morbid obesity.